New study shows marijuana manages Crohn's Disease
People have been using cannabis to help manage their symptoms resulting from Crohn’s Disease for quite some time now. A newly released paper adds evidence to support marijuana’s efficacy for sufferers of the disease.
The journal Pharmacology published a new paper titled ‘Cannabis Finds Its Way into Treatment of Crohn’s Disease’ wherein researchers state that, “in agreement with the ancient use of cannabis in intestinal disturbances and one decade of animal research, cannabis was shown in a clinical trial to reduce symptoms in patients with Crohn’s disease.”
The 2014 paper endorses a groundbreaking, but small study in 2013 that showed that pot caused a “complete remission” of Crohn’s Disease with no side effects.
While researchers aren’t sure of the exact reasons why marijuana is effective medicine for this disease, evidence points to molecules in cannabis affecting cells in the stomach and brain to stop inflammation and lessen sensations of pain and nausea.
Researchers are calling for more studies on the matter, however the federal government largely prevents any study for medical purposes. Most studies allowed by the federal government are geared towards trying to find evidence of marijuana being a dangerous substance, despite it being a non-toxic plant.
Cannabis is federally classified as a Schedule 1 drug, and is considered to have no medical benefit with a high potential for abuse.
Crohn’s disease is a form of inflammatory bowel disease (IBD). It usually affects the intestines, but may occur anywhere from the mouth to the end of the rectum (anus). Ulcerative colitis is a related condition.